myplant dental Germany

What myplant dental Germany does

myplant dental Germany is the commercial brand of Sirowa Biotechnologies GmbH, a private medical device company headquartered in Neuss, Germany, that designs, develops, and distributes dental implant systems and bone grafting biomaterials. The company was formed as a joint venture combining a German dental manufacturing specialist with an international corporate group experienced in dental implant marketing and distribution; since 2025 it has operated independently. The legal entity has 11-50 employees and is registered in Selters, Germany, under Sirowa Biotechnologies GmbH.

The product portfolio comprises three core lines. myplant bio is a hybrid dental implant that combines a titanium core with a proprietary Cerid® high-vacuum ceramic coating (approximately 4-7 micrometers thick, biocompatibility index of 1) and a Niob® titanium-niobium-nitride abutment coating, positioning it for titanium-hypersensitive patients. myplant two is a two-phase titanium implant with an expansion thread and self-locking cone abutment connection, designed over 30 years ago by Prof. Dr. med. dent. Nentwig and Dr.-Ing. Moser. AlgOss provides bone grafting materials derived from marine red algae — AlgOss 100 (pure hydroxyapatite) and AlgOss 20-80 (biphasic 20% HA / 80% β-TCP) — for ridge augmentation, sinus elevation, and periodontal defects. The company also publishes CAD/CAM digital libraries for Exocad, 3Shape, Dental Wings, and Hypsocad platforms.

myplant operates a B2B hardware sales model, generating revenue from implant systems, prosthetic components, surgical instruments, and biomaterials sold to dental professionals — primarily oral surgeons, periodontists, and implantologists — across five primary European markets (Germany, UK, Italy, Poland, Turkey), with the United States explicitly excluded. Distribution combines direct sales from the Neuss headquarters, wholly-owned sales subsidiaries in Italy (myplant Italia Srl) and the UK (myplant Biotechnologies UK Ltd), and channel partners in Poland (SIROWA/LFM Poland, merging as of January 2025) and Turkey. Pricing is quote-based and not publicly disclosed. Marketing relies on a multilingual website (DE, EN, IT, PL, TR), CAD/CAM digital library downloads, sales brochures, clinical interviews, and a call centre, supplemented by social media presence on Facebook, Instagram, and LinkedIn. The company holds EU MDR (Medical Device Regulation 2017/745) certification.

Name

myplant dental Germany

Legal name

Sirowa Biotechnologies GmbH

Website

https://myplant-dental.com

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

11–50 employees

Short description

myplant dental Germany (legal entity Sirowa Biotechnologies GmbH) is a Neuss-based medical device company that designs, manufactures, and distributes dental implant systems (myplant bio, myplant two) and algae-derived bone graft materials (AlgOss) to dental professionals across Germany, the UK, Italy, Poland, and Turkey.

Ownership category

akta.pro rank

Product category

Dental Implant Systems

NAICS

Dental Laboratories (339116), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Dental Implants & Prosthodontic Components (Implants/Abutments/Prosthetics) (HLAHAEAE)

akta.pro secondary industries

Implant Prosthetics & Abutment Fabrication (HLABAJAC), Implant Prosthodontics (Implant-Supported Restorations) (HLABAFAC), Dental Implant Surgery & Bone Grafting (HLABAEAB)

Keywords

• Dental implant systems
• Bone grafting materials
• Ceramic-coated titanium implants
• Algae-derived biomaterials
• CAD/CAM implant libraries

Headquarters

HQ city

Neuss

HQ country

Germany

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Dental Implant Systems (myplant bio & myplant two): Revenue generated from the sale of dental implant systems, including hybrid ceramic-coated titanium implants (myplant bio) and two-phase titanium implants (myplant two), along with associated prosthetic components and surgical instruments. Sales conducted through direct channels and regional distribution partners across multiple international markets.
2. Bone Grafting Materials (AlgOss): Revenue from AlgOss brand bone grafting materials, including AlgOss 100 (pure phycogenic hydroxyapatite) and AlgOss 20-80 (biphasic HA/beta-TCP composite), derived from marine red algae and used in dental bone augmentation procedures.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels6 records

Core offering

myplant GmbH develops, manufactures, and distributes dental implant systems (myplant bio hybrid ceramic-coated titanium implants and myplant two two-phase titanium implants) along with AlgOss bone grafting materials derived from marine red algae. The products are sold to dental professionals (oral surgeons, periodontists, implantologists) and dental laboratories across Germany, the UK, Italy, Poland, Turkey, and additional international markets through direct sales and exclusive distribution partners.

Product overview

myplant GmbH offers a comprehensive portfolio of dental implant solutions and biomaterials. The core offerings include myplant bio (a hybrid dental implant combining titanium mechanical stability with bioceramic surface coating), myplant two (a two-phase titanium implant system with proven expansion thread design), and AlgOss (bone graft materials derived from marine red algae). The company represents an alliance of over 30 years of dental implant manufacturing and development expertise, serving dental professionals with products designed and manufactured in Germany.

Differentiator

Problem solved

Functional benefit

Brands

• myplant bio: Hybrid dental implant system combining tissue-friendly ceramic properties with technical advantages of titanium implants
• myplant two
• AlgOss

Products and services

• myplant bio A hybrid dental implant combining the mechanical stability of titanium with tissue-friendly ceramic properties. The titanium abutment and implant body are encased in a high-strength biocompatible ceramic layer (approximately 4-7 micrometers thick) applied via a proprietary high-vacuum coating process. Achieves a biocompatibility index of 1, prevents titanium ion release and particle abrasion, and is suitable for titanium-hypersensitive patients. Indicated for dental professionals performing implant surgery across single-tooth, bridge, and full-arch restorations.
• myplant two A two-phase titanium dental implant system with a special expansion thread design and self-locking cone abutment connection. Features a micro-movement-free and bacteria-proof implant-abutment connection, deep platform switching, and supports subcrestal placement. Designed for dental professionals performing implant procedures across single-tooth, bridge, and full-arch restorations.
• AlgOss Bone grafting biomaterial derived from marine red algae (phycogenic). AlgOss 100 is pure hydroxyapatite granulate, while AlgOss 20-80 is a biphasic composite (20% hydroxyapatite and 80% β-tricalcium phosphate) for accelerated bone regeneration. Used by dental professionals for alveolar ridge augmentation, maxillary sinus elevation, cystectomy defects, periodontal defects, extraction socket grafting, and guided tissue/bone regeneration. Suitable for patients with ethical, religious, or dietary restrictions due to its plant-based origin.

Quantifiable outcome

• Biocompatibility index of 1 (100%) for Cerid® ceramic surface, superior to titanium implants
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature8 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Sirowa Biotechnologies GmbHcoreStrategic or Co-development Partner · 1 January 2025Sirowa Biotechnologies GmbH (registered in Selters, Germany) is the parent company and joint venture partner behind myplant GmbH. The joint venture combines Sirowa's dental implant manufacturing expertise with international implant distribution experience. Sirowa provides the manufacturing and development competency across proven implant systems.
• myplant Italia SrlcoreChannel Partner/ Reseller/ Distributormyplant Italia Srl, based in Parma, Italy (Viale Vittoria 13), serves as the Italian sales and distribution entity for myplant products. The company is managed by Francesco Maggioni (Managing Director) and provides customer service, sales support, and data protection oversight for the Italian market.
• myplant Biotechnologies UK LtdcoreChannel Partner/ Reseller/ Distributormyplant Biotechnologies UK Ltd, based in Bournemouth, UK, serves as the UK sales entity with exclusive distribution partners. VAT No. 300 451 072.
• SIROWA Poland Sp. z o. o. / LFM Poland Sp. z o. o.coreChannel Partner/ Reseller/ DistributorSIROWA Poland Sp. z o. o. and LFM Poland Sp. z o. o. serve as distribution entities in the Polish market. A merger plan between the two entities was announced in January 2025 according to Polish commercial code requirements.
• Meisinger Italy SrlminorChannel Partner/ Reseller/ DistributorMeisinger Italy Srl (Tel. +39 0521 162 75 57) is referenced as a distribution partner in Italy, alongside the direct operations of myplant Italia Srl.
• Prof. Dr. med. dent. Nentwig and Dr.-Ing. MosercoreStrategic or Co-development PartnerProf. Dr. med. dent. Nentwig and Dr.-Ing. Moser are the original developers of the two-phase titanium implant concept with expansion thread and self-locking cone abutment connection, developed over 30 years ago and brought to clinical maturity. Their foundational research and design work underlies the myplant two implant system.

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Bredent: German dental implant and biomaterial manufacturer with a comparable mid-sized European footprint and similar focus on implant systems plus restorative components, competing with myplant in the DACH region.
• Geistlich Pharma: Swiss-based leader in dental bone regeneration (Bio-Oss, Bio-Gide) — the dominant incumbent in the bone graft category against which myplant's AlgOss algae-derived portfolio directly competes.
• Straumann: Global leader in premium dental implants and prosthetics, with a directly competing portfolio (including ceramic implant systems such as Straumann PURE Ceramic). Straumann competes head-on with myplant bio and myplant two in the European implant market and dwarfs myplant in scale, R&D, and clinical evidence.
• Nobel Biocare: Premium dental implant manufacturer (part of Envista) with comparable product positioning to myplant bio and myplant two, including emphasis on surface technologies and digital workflow integration. Direct competitor in European implantology.
• BioHorizons (Henry Schein): Dental implant and tissue regeneration specialist owned by Henry Schein, offering a comparable range of implant systems and bone graft materials to myplant's myplant two and AlgOss products.
• Camlog (Henry Schein): German-headquartered dental implant manufacturer (now part of Henry Schein) with directly comparable products, German manufacturing heritage, and European distribution overlap — the closest domestic peer to myplant.
• MIS Implants Technologies (Envista): Dental implant manufacturer offering a comparable portfolio of titanium implant systems with surface treatments and prosthetic components, competing against myplant in price-sensitive and value segments of the European market.

Broad incumbents

• Dentsply Sirona: Broad incumbent in dental equipment and implants (Astra Tech, Xive, Ankylos brands). Competes with myplant across implant categories but operates as a multi-product dental conglomerate rather than a focused implant specialist.
• Zimmer Biomet Dental: Diversified orthopedic and dental implant business (part of Zimmer Biomet) competing broadly with myplant in dental implants and prosthetics, but operating as a multi-billion-dollar medical device conglomerate rather than a focused specialist.

Emerging players

• Z-Systems: Swiss specialist in ceramic dental implants with directly comparable positioning to myplant bio in the all-ceramic and metal-free implant niche, serving similar titanium-hypersensitive and aesthetic-driven patient segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/myplantdental
• LinkedInlinkedin.com/company/myplantdentalgermany
• Instagraminstagram.com/myplant_dental

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about myplant dental Germany